Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis

(2012) Yuni Choi et al.   INTERNATIONAL JOURNAL OF CANCER

Difficulty in predicting survival in metastatic renal cancer

(2012) Tom Powles et al.   LANCET ONCOLOGY

Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma

(2011) Michael S. Sabel et al.   ANNALS OF SURGICAL ONCOLOGY

The growing challenge of obesity and cancer: an inflammatory issue

(2011) Alison E. Harvey et al.   Annals of the New York Academy of Sciences

Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor-Targeted Therapy?

(2011) S. Steffens et al.   ONCOLOGIST

Visceral Fat Area as a New Independent Predictive Factor of Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Antiangiogenic Agents

(2011) S. Ladoire et al.   ONCOLOGIST

Impact of Body Composition on Clinical Outcomes in Metastatic Renal Cell Cancer

(2011) P. A. Tang et al.   ONCOLOGIST

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer

(2010) Lee W. Jones et al.   CANCER

Phase 3 trial of everolimus for metastatic renal cell carcinoma

(2010) Robert J. Motzer et al.   CANCER

Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer

(2010) Sandra Waalkes et al.   CANCER CAUSES & CONTROL

Influence of Visceral Obesity on Oncologic Outcome in Patients with Renal Cell Carcinoma

(2010) Yukio Naya et al.   UROLOGIA INTERNATIONALIS

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

(2009) C. M.M. Prado et al.   CLINICAL CANCER RESEARCH

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

(2009) Bernard Escudier et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

(2009) Daniel Y.C. Heng et al.   JOURNAL OF CLINICAL ONCOLOGY

Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults?

(2009) Peggy Mannen Cawthon et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Prognostic Value of the Six-Minute Walk in Advanced Non-small Cell Lung Cancer

(2009) Goulnar Kasymjanova et al.   Journal of Thoracic Oncology

Prognostic Value of Body Mass Index in Korean Patients With Renal Cell Carcinoma

(2009) Hwang Gyun Jeon et al.   JOURNAL OF UROLOGY

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY